Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial
Public ClinicalTrials.gov record NCT05046561. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Study to Reinforce Immunity (STRI) - A Phase 2 Double-Blind, Randomized, Placebo-Controlled Study to Investigate The Safety and Efficacy of STRI Formula in Non-Hospitalized Participants With COVID-19
Study identification
- NCT ID
- NCT05046561
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Eyecheck, Inc.
- Industry
- Enrollment
- 598 participants
Conditions and interventions
Conditions
Interventions
- STRI Formula Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 3, 2021
- Primary completion
- Nov 30, 2022
- Completion
- Jul 31, 2023
- Last update posted
- Sep 8, 2022
2021 – 2023
United States locations
- U.S. sites
- 13
- U.S. states
- 3
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Luna Research | Coral Gables | Florida | 33134 | Recruiting |
| Prohealth Research Center | Doral | Florida | 33166 | Not yet recruiting |
| Solution Clinical Research | Doral | Florida | 33178 | Recruiting |
| South Florida Research | Medley | Florida | 33166 | Recruiting |
| G+C Research Group | Miami | Florida | 33126 | Recruiting |
| Dynamic Medical Research | Miami | Florida | 33144 | Recruiting |
| Vista Health | Miami | Florida | 33176 | Recruiting |
| Davila Medical Research | Miami | Florida | 33184 | Recruiting |
| A&A Research Group | Miami | Florida | 33186 | Recruiting |
| The Miami Research Group | Miami | Florida | 33186 | Not yet recruiting |
| Affinity Clinical Research | Tampa | Florida | 33612 | Recruiting |
| Beat COVID | Oak Forest | Illinois | 60452 | Recruiting |
| Dorisca Research Consulting | Houston | Texas | 77090 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05046561, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 8, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05046561 live on ClinicalTrials.gov.